Searched for
DRUG MANUFACTURING IN USA
Germany's Bayer to invest $2.2 billion in US pharma siteBayer has announced a significant investment of $2.2 billion to establish a new pharmaceutical site in New Albany, Ohio. This project follo...- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhat is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...
- FDA Chlorthalidone dissolution testing recall: More than 25,000 bottles of blood pressure medication recalled. Check which tablets are impacted?Blood Pressure tablets FDA chlorthalidone dissolution testing recall: Chlorthalidone medication is prescribed to keep the blood pressure in...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThere are times when a watchlist is more important than a buy list. But if you still insist on putting money in the market, look at fundame...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilarCipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s can...
- USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observationsAurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducte...
- Zydus Lifesciences gets USFDA nod for generic ascorbic acid injectionZydus Lifesciences secured final USFDA approval for its generic ascorbic acid injection. This approval is for the treatment of scurvy in sp...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Aurobindo, Glenmark, FDC recall products in US market over manufacturing issues: USFDAThe New Jersey-based Aurobindo Pharma USA Inc initiated the Class 1 recall on July 11, it said. As per the US health regulator, a Class I r...
- Indian drug firms recall various products in US marketWhile Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid.
- Zydus group firm Nesher Pharmaceuticals gets USFDA nod for a drug"The drug falls in the CNS stimulant segment and is the first product to be developed by the R&D team at Nesher," it added.
- Micro Labs recalls 54,096 bottles of cholesterol drug in USMicro Labs is voluntarily recalling 54,096 bottles of Simvastatin Tablets, a drug for lowering cholesterol, in the US market for failing to...
- India wants its officials during USFDA inspections at drug unitsIn many cases, these companies have been barred from selling their drugs in the US and other countries, although Indian firms account for a...
- Wockhardt, Cadila and Hospira voluntarily recall drugs in USDrug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in US, according to the US Food and Dru...
- Cadila Healthcare recalls blood pressure drug in the USThe recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc.
- Ranbaxy facilities under review: Gulam Nabi AzadRanbaxy facilities in India are being reviewed after its US arm admitted to manufacturing certain drugs not in conformity with good practic...
- Ranbaxy reassures South Africans local drugs are safeRanbaxy has assured the public that drugs manufactured locally are safe days after the Indian firm paid a fine of $500 million in the US.
- Ranbaxy to pay $500 mn to US Department of Justice for settlement of felony charges related to drug safetyRanbaxy pleaded guilty to felony charges related to drug safety & will pay $500 mn in fines under settlement agreement with US Department o...
Load More
